Reference no: EM132180793

Should the terminally ill be asked to await FDA approval of the last chance treatment:

Social, policy, and ethical considerations:

1. if it was your mother what recommendation would you make. Under the circumstances, is it unethical to use a drug that has not been approved by the FDA?

2. As a policy matter, how should the FDA handle drugs for life threatening diseases?

3. Should individuals be allowed absolute freedom to risk with drug therapy?

4. Should FDA apply different drug approval standards with regards to children who suffer from life threatening diseases?

5. As policy matter, how should the government and nonprofit organizations allocate resources among research groups competing for funding? How should the government, through its administrative agencies, establish priorities for funding research on various illnesses?